Ibere Pharmaceuticals Statistics Share Statistics Ibere Pharmaceuticals has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 12.47M Failed to Deliver (FTD) Shares 193,358 FTD / Avg. Volume 229.29%
Short Selling Information The latest short interest is 15.73K, so 0% of the outstanding
shares have been sold short.
Short Interest 15.73K Short % of Shares Out n/a Short % of Float 0.11% Short Ratio (days to cover) 4.55
Valuation Ratios The PE ratio is 71.52 and the forward
PE ratio is null.
Ibere Pharmaceuticals's PEG ratio is
0.
PE Ratio 71.52 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.88 P/FCF Ratio -128.6 PEG Ratio 0
Financial Ratio History Enterprise Valuation Ibere Pharmaceuticals has an Enterprise Value (EV) of 111.26M.
EV / Sales 0 EV / EBITDA -31.32 EV / EBIT -128.07 EV / FCF -128.07
Financial Position The company has a current ratio of 1.86,
with a Debt / Equity ratio of 0.
Current Ratio 1.86 Quick Ratio 1.86 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 1.23% and Return on Invested Capital is -0.73%.
Return on Equity 1.23% Return on Assets 1.13% Return on Invested Capital -0.73% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Ibere Pharmaceuticals's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.13 200-Day Moving Average n/a Relative Strength Index (RSI) 58.6 Average Volume (20 Days) 84,328
Income Statement
Revenue n/a Gross Profit -1M Operating Income -1M Net Income 1.56M EBITDA -3.55M EBIT -1M Earnings Per Share (EPS) 0.34
Full Income Statement Balance Sheet The company has 458.39K in cash and 0 in
debt, giving a net cash position of 458.39K.
Cash & Cash Equivalents 458.39K Total Debt n/a Net Cash n/a Retained Earnings -10.85M Total Assets 138.96M Working Capital -355.8K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -868.75K
and capital expenditures 0, giving a free cash flow of -868.75K.
Operating Cash Flow -868.75K Capital Expenditures n/a Free Cash Flow -868.75K FCF Per Share -0.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
